Viewing Study NCT06387056


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2025-12-31 @ 6:33 PM
Study NCT ID: NCT06387056
Status: RECRUITING
Last Update Posted: 2024-04-26
First Post: 2024-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Sponsor: The First Affiliated Hospital of Xiamen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module